Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Mexico
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts
Essential resource for top-line data and analysis covering the Mexico pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Reasons To Buy
What was the size of the Mexico pharmaceuticals market by value in 2015?
What will be the size of the Mexico pharmaceuticals market in 2020?
What factors are affecting the strength of competition in the Mexico pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in Mexico's pharmaceuticals market?
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.
The Mexican pharmaceuticals market had total revenues of $8.4bn in 2015, representing a compound annual growth rate (CAGR) of 1.3% between 2011 and 2015.
A growing middle class and better access to health care services are greatly increasing consumer demand for pharmaceutical products in Mexico.
The performance of the market is forecast to accelerate, with an anticipated CAGR of 2.2% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $9.3bn by the end of 2020.